Pasar al contenido principal

BIOMARCADORES INMUNOLOGICOS ANTIGENO-ESPECIFICOS (CELULAS T) ASOCIADOS AL CONTROL DE LA INFECCION POR T. CRUZI.

SAF2016-81003-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Longitudinal monitoring of anti-saliva antibodies as markers of repellent efficacy against Phlebotomus perniciosus and Phlebotomus papatasi in dogs

  • Risueño, José
  • Spitzová, T
  • Bernal, Luis J.
  • Muñoz, Clara
  • López López, Manuel Carlos
  • Thomas, María del Carmen
  • Infante, J. J.
  • Volf, P.
  • Berriatua, Eduardo
A 2-year longitudinal study of enzyme-linked immunosorbent assay (ELISA) antibodies against Phlebotomus perniciosus and Phlebotomus papatasi (Diptera: Psychodidae) sandfly saliva was performed in 32 Beagle dogs treated preventively with an imidacloprid-permethrin topical insecticide in an endemic area in Spain. Dogs were grouped into three sandfly exposure groups according to the time of inclusion in the study. Assays analysed immunoglobulin G (IgG) against salivary gland homogenates (SGH) of both species and recombinant P. papatasi rSP32 and P. perniciosus rSP03B proteins in serum. The dogs were participating in a Leishmania infantum (Kinetoplastida: Trypanosomatidae) vaccine trial and were experimentally infected with the parasite in the second year. No dog acquired natural L. infantum infections during the first year, but most developed anti-saliva antibodies, and median log-transformed optical densities (LODs) were seasonal, mimicking those of local sandflies. This indicates that the repellent efficacy of the insecticide used is below 100%. Multi-level modelling of LODs revealed variability among dogs, autocorrelation and differences according to the salivary antigen and the dog's age. However, dog seroprevalence, estimated using pre-exposure LODs as cut-offs, was relatively low. This, and the fact that dogs did not become naturally infected with L. infantum, would support the efficacy and usefulness of this imidacloprid-permethrin topical insecticide in canine leishmaniasis control., The project was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (grants Pr. Ref. AGL2013-46981-R, RTC-2016-50005-1, SAF2016-81003-R and SAF2016-80998-R), the Instituto de Salud Carlos III within the Network of Tropical Diseases Research RICET (RD16/0027/0016 and RD16/0027/0005) and (FEDER). The authors of this paper are members of and receive support from COST Action TD1303 (European Network for Neglected Vectors and Vector-Borne Infections), INFRAVEC 2 (Research Infrastructures for the Control of Vector-Borne Diseases, H2020, no. 731060) and VectorNet, a European network for sharing data on the geographic distribution of arthropod vectors transmitting human and animal disease agents (contract OC/EFSA/AHAW/2013/02-FWC1) funded by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). TS and PV were supported by Ministry of Education, Youth and Sport of the Czech Republic (MSMT) (project OPVVV 16-019/0000759) and Charles University (Research Centre UNCE 204072)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection

  • Egui, Adriana
  • Thomas, María del Carmen
  • Fernández-Villegas, A.
  • Pérez-Antón, Elena
  • Gómez, Inmaculada
  • Carrilero, Bartolomé
  • del Pozo, Angel
  • Ceballos, Maialen
  • Andrés-León, Eduardo
  • López-Ruz, M. A.
  • Gainza, Eusebio
  • Oquiñena, Enrique
  • Segovia, Manuel
  • López López, Manuel Carlos
One of the current greatest challenges of Chagas disease is the establishment of biomarkers to assess the efficacy of drugs in a short period of time. In this context, the reactivity of sera from 66 adults with chronic indeterminate Chagas disease (IND) for a set of four Trypanosoma cruzi antigens (KMP11, PFR2, HSP70, and 3973(d)) was analyzed before and after benznidazole treatment. The results showed that the reactivity against these antigens decreased at 9, 24, and 48 months after treatment. Moreover, the 42.4% and 68.75% of IND patients met the established standard criteria of therapeutic efficacy (STEC at 24 and 48 months posttreatment, respectively. Meeting the STEC implied that there was a continuous decrease in the reactivity of the patient sera against the four antigens after treatment and that there was a substantial decrease in the reactivity for at least two of the antigens. This important decrease in reactivity may be associated with a drastic reduction in the parasite load, but it is not necessarily associated with a parasitological cure. After treatment, a positive PCR result was only obtained in patients who did not meet the STEC. The percentage of granzyme B+ /perforin(+) CD8(+) T cells was significantly higher in patients who met the STEC than in those who did not meet the STEC (35.2% versus 2.2%; P < 0.05). Furthermore, the patients who met the STEC exhibited an increased quality of the multifunctional response of the antigen-specific CD8(+) T cells compared with that in the patients who did not meet the STEC., This work was financially supported by grants SAF2016-81003-R, SAF2016-80998-R, and RTC-2014-2130 from the Programa Estatal I + D + i (MINECO); the Network of Tropical Diseases Research RICET (RD16/0027/0005 and RD16/0027/0016); and FEDER. This publication is part of the PhD thesis of the student Elena Perez-Anton at the University of Granada in the Biomedicine Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Perfil de respuesta inmunitaria de células T asociada a la protección frente a la re-infección por T. cruzi

  • Egui, Adriana
  • Lasso, Paola
  • Thomas, María del Carmen
  • Puerta, Concepción J.
  • Cuéllar, Adriana
  • López López, Manuel Carlos
Introducción: La enfermedad de Chagas representa un problema de salud pública global, que en su fase crónica implica un alto coste para el sistema de salud y a nivel laboral. No existe un tratamiento antiparasitario efectivo que produzca el aclaramiento del parásito y es escaso el conocimiento sobre los mecanismos que operan en protección. Así, el estudio de la dinámica de las poblaciones de linfocitos T asociados a protección permitirá nuevas aproximaciones terapéuticas. Objetivos: Analizar los procesos de primo- y re-infección con distintas cepas de T. cruzi en un modelo murino de infección experimental al objeto de determinar los patrones inmunológicos a activar para la obtención de una eficaz inmunoterapia frente al Chagas crónico. Materiales y Métodos: Infección experimental con T. cruzi en ratones Balb/c por vía intraperitoneal (5x102 tripomastigotes (primo-infección); 5x105 y 1x105 (re-infección) cepas Y(DTU-II) y SOL(DTUV), respectivamente. Detección anticuerpos antígeno-específicos (IgG e IgG1/IgG2a) mediante ELISA. El análisis del fenotipo y funcionalidad de las células T antígeno-específicas se realizó empleando citometría de flujo multiparamétrica. Resultados: Ratones en fase crónica de la infección por T. cruzi controlan la parasitemia que induce la re-infección con dicho parásito. Este comportamiento está asociado a un claro perfil inmunológico caracterizado por una mayor proporción de células T CD4+ y CD8+ de memoria central (TCM) y efectora (TEM). Asimismo, los ratones re-infectados presentan mayor porcentaje de células T CD8+ multifuncionales que producen IFN-¿, Granzima B y TNF¿ y menor frecuencia de aquellas que expresan los receptores inhibitorios PD-1 y CD160. Las células T CD4+ de los ratones re-infectados muestran una mayor proporción de células que expresan PD-1 y CTLA-4. Conclusiones: Los ratones en fase crónica de infección por T.cruzi controla la re-infección por dicho parásito, asociada a la presencia de una alta frecuencia de células T CD8+ antígeno-específicas de memoria con capacidad multifuncional. Financiación: Programa Estatal I+D+I (MINECO) Ref. SAF2016-81003R y SAF2016- SAF2016-80996-R; Red de Investigación en Enfermedades Tropicales (RICET) Ref. RD16/0027/0005, (ISCIII), España.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Perfil fenotípico de las células CD8+ epítope-específicas como biomarcador de respuesta al tratamiento con benznidazol

  • Egui, Adriana
  • Gómez, Inmaculada
  • Simón, Marina
  • Segovia, Manuel
  • López López, Manuel Carlos
  • Thomas, María del Carmen
Uno de los mayores desafíos en la investigación de la enfermedad de Chagas es la búsqueda de herramientas que permitan evaluar la eficacia del tratamiento. Estudios previos del laboratorio mostraron que los antígenos KMP11, PFR2, HSP70 y 3973d de T. cruzi son reconocidos por sueros de pacientes crónicos con alta especificidad. El uso de estos antígenos como set de biomarcadores, ¿Chagnostik¿, permitió establecer un criterio de eficacia terapéutica, basado en la disminución continua y sustancial de la reactividad de los sueros frente a dichas moléculas. Estos biomarcadores serológicos junto a la evaluación de parámetros inmunológicos celulares podría ser una potente herramienta de seguimiento terapéutico. ., Programa Estatal I+D+I (SAF2016-81003-R y SAF2016-80996-R); Red de Investigación en Enfermedades Tropicales (RD16/0027/0005 y RD16/0027/0016) y FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evaluation of the circadian rhythm of anti-Leishmania IgG2 and IgA antibodies in serum and saliva of dogs with clinical leishmaniosis

  • Cantos-Barreda, A.
  • Escribano, Damián
  • Egui, Adriana
  • López López, Manuel Carlos
  • Cerón, José J.
  • Bernal, Luis J.
  • Martínez-Subiela, S.
In this study, the circadian rhythm of IgG2 and IgA specific antibodies in serum and saliva samples of 6 dogs experimentally infected with Leishmania infantum was assessed. Sampling was performed at 8.00, 12.00, 16.00, 20.00, and 00.00 h on two consecutive days. Anti-Leishmania antibody levels in serum were expressed without any correction, whereas in saliva were shown in different ways: without any correction, adjusted by protein concentration and corrected by the salivary flow rate. No significant differences in anti-Leishmania IgG2 antibody levels in serum and saliva samples with or without correction were found. Significant differences were found when anti-Leishmania IgA levels were corrected by the salivary flow rate. In addition, a greater intra-individual variation of antibody levels was observed in saliva than in serum. However, this variation did not modify the serological status of the dogs. Therefore, it could be concluded that there is no circadian rhythm in serum and saliva samples and sampling can be performed at any time of the day., We thank ADL-Bionatur for supplying the dogs for the study. ACB is supported by a pre-doctoral FPU fellowship from the University of Murcia,Spain.DE held a post-doctoral“Juandela Cierva Formación ”fellowship from“Ministerio de Economíay Competitividad”(MINECO),Spain. AE and MCL were supported by grants RTC-2016-50005-1 and SAF2016-81003-R from the “Programa Estatal I+D+I” from MINECO and by the Network of Tropical Diseases Research RICET(RD16/0027/0005)funded by ISCIII and FEDER.This project was supported by grant 19894/GERM/15 of the Seneca Foundation of Murcia Region (Groups of Excellence).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immunological exhaustion and functional profile of CD8+ T lymphocytes as cellular biomarkers of therapeutic efficacy in chronic Chagas disease patients

  • Pérez-Antón, Elena
  • Egui, Adriana
  • Thomas, María del Carmen
  • Simón, Marina
  • Segovia, Manuel
  • López López, Manuel Carlos
The lack of useful tools for detection the impact of treatment during the follow-up of chronic Chagas disease treated patients difficult the adequate care to the affected population. The objective of this study was to evaluate the functional response of CD8 T lymphocyte population, critical for the control of Trypanosoma cruzi infection, as a possible cellular biomarker of treated Chagas disease patients. Thus, we analyzed the antigen-specific CD8 T-cell response before and after benznidazole treatment in asymptomatic (indeterminate) and cardiac chronic Chagas disease patients. A marked dysfunctional process of the CD8 T cell population was found in patients with an advanced pathology. Thus, the cardiac patients have a higher co-expression of inhibitory receptors and a lower antigen-specific multifunctional capacity compared with that of asymptomatic patients. Remarkably, benznidazole treatment partially reverses this functional exhaustion process of CD8 T cells in both asymptomatic and cardiac Chagas disease patients. Thus, the co-expression of inhibitory molecules tends to be reduced after benznidazole treatment, mainly in asymptomatic patients, finding a significant drop in the expression of inhibitory receptors such as PD-1 and 2B4. In addition, the multifunctional antigen-specific response of CD8 T cells is enhanced after treatment in chronic patients. An increase in the subset of cells with cytotoxic capacity and production of the IFN-γ cytokine was also observed in both treated asymptomatic and cardiac chronic Chagas disease patients. The results derived from this study show the improvement of the functional capacity of CD8 T cells after treatment which could be have a positive effect on parasitic control. In addition, the phenotypic and functional profile of the CD8 T cells described could serve as a tool for monitoring the impact of benznidazole treatment., We thank the patients and healthy volunteers who participated in this study. We also thank Dr. Bartolomé Carrilero (Hospital Virgen de la Arrixaca, Murcia) for contributions to the recruitment and medical examination of Chagas disease patients. This work was financially supported by grants SAF2016-81003-R, SAF2016-80998-R from the Programa Estatal I+D+i (MINECO); the Network of Tropical Diseases Research RICET (RD16/0027/0005 and RD16/0027/0016) and FEDER. This publication is part of the PhD thesis of student Elena Pérez Antón at the University of Granada in the Biomedicine Program.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Serum proteome of dogs at subclinical and clinical onset of canine leishmaniosis

  • Franco-Martínez, Lorena
  • Villar, Margarita
  • Tvarijonaviciute, Asta
  • Escribano, Damián
  • Bernal, Luis J.
  • Cerón, José J.
  • Thomas, María del Carmen
  • Mateos-Hernández, Lourdes
  • Tecles, Fernando
  • Fuente, José de la
  • López López, Manuel Carlos
  • Martínez-Subiela, Silvia
The objective of this study was to identify changes in serum proteome in dogs that may occur after an experimental infection at subclinical and clinical stages of canine leishmaniosis (CanL). For this purpose, canine pre‐ and post‐infection with Leishmania infantum serum proteomes in the same dogs were analysed by a high‐throughput label‐based quantitative LC‐MS/MS proteomic approach. A total of 169 proteins were identified, and 74 of them including complement C8 alpha chain, adiponectin, transferrin, sphingomyelin phosphodiesterase acid‐like 3A and immunoglobulins showed different modulation between the different stages of CanL. These proteins could be considered as potential serum biomarkers of early diagnostic or disease progression in CanL. Additionally, biological pathways modulated during CanL such as blood coagulation or gonadotropin‐releasing hormone receptor were revealed, which could help to understand the pathological mechanisms of the disease., LFM was granted with predoctoral contract ‘FPU' of University of Murcia, Spain. MV was supported by Research Plan of University of Castilla‐ La Mancha, Spain. AT has a postdoctoral fellowshisp ‘Ramón y Cajal' supported by the ‘Ministerio de Economía y Competitividad', Spain. MCT and MCL were supported by grants SAF2016‐81003‐R, SAF2016‐80996‐R, and RTC‐2016‐50005‐1 from the ‘Programa Estatal I+D+I' (MINECO). This work was supported by a grant from the Program for Research Groups of Excellence of the Seneca Foundation, Murcia, Spain (grant 19894/GERM/15)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Target product profile for a test for the early assessment of treatment efficacy in chagas disease patients: An expert consensus

  • Alonso-Padilla, Julio
  • Abril, Marcelo
  • de Noya, B.A.
  • Almeida, Igor C.
  • Angheben, A.
  • Jorge, T.A.
  • Chatelain, E.
  • Esteva, Monica
  • Gascón, Joaquim
  • Grijalva, M.J.
  • Guhl, Felipe
  • Hasslochermoreno, A.M.
  • López López, Manuel Carlos
  • Luquetti, A.
  • Noya, O.
  • Pinazo, M.J.
  • Ramsey, J.M.
  • Ribeiro, I.
  • Ruiz, A.M.
  • Schijman, A.G.
  • Sosa-Estani, S.
  • Thomas, María del Carmen
  • Torrico, F.
  • Zreinid, M.
  • Picado, A.
descripción no proporcionada por scopus, ISGlobal work is supported by the Departament d’Universitats i Recerca de la Generalitat de Catalunya, Spain (AGAUR; 017SGR00924) and by the Instituto de Salud Carlos III (ISCIII) RICET Network for Cooperative Research in Tropical Diseases (ISCIII; RD16/0027/0004 - PI1290) and FEDER. MJP research is supported by the Ministry of Health, Government of Catalonia (PERIS 2016-2010 SLT008/18/00132). ICA, JG, and FT are supported by the grant number U01AI129783 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). ICA is also partly supported by the grant number 5U54MD007592 from the National Institute on Minority Health and Health Disparities (NIMHD), NIH. MCL and MCT were supported by ISCIII RICET grant RD16/0027/0005 - PI1290 and FEDER and by grants SAF2016-81003-R and SAF2016-80998-R from the Spanish “Programa Estatal I+D+i (MINECO)”. AA's work was supported by the Italian Ministry of Health “Fondi Ricerca Corrente - Linea 3, progetto 9” to IRCCS Sacro Cuore Don Calabria Hospital. JR was supported by CONACyT Fossis grant #261006. The Drugs for Neglected Diseases initiative (DNDi) is grateful to its donors, public and private, who have provided funding to DNDi since its inception in 2003. A full list of DNDi's donors can be found at http://www.dndi.org/donate/donors/. FIND is grateful to its donors, public and private, who have helped bring innovative new diagnostics for diseases of poverty. A full list of FIND’s donors can be found at: https://www.finddx.org/partners-donors/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcriptional profiling of immune-related genes in Leishmania infantum-infected mice: Identification of potential biomarkers of infection and progression of disease

  • Ontoria, E
  • Hernández-Santana, Y.E.
  • González-García, Ana C.
  • López López, Manuel Carlos
  • Valladares, Basilio
  • Carmelo, Emma
Leishmania spp. is a protozoan parasite that affects millions of people around the world. At present, there is no effective vaccine to prevent leishmaniases in humans. A major limitation in vaccine development is the lack of precise understanding of the particular immunological mechanisms that allow parasite survival in the host. The parasite-host cell interaction induces dramatic changes in transcriptome patterns in both organisms, therefore, a detailed analysis of gene expression in infected tissues will contribute to the evaluation of drug and vaccine candidates, the identification of potential biomarkers, and the understanding of the immunological pathways that lead to protection or progression of disease. In this large-scale analysis, differential expression of 112 immune-related genes has been analyzed using high-throughput qPCR in spleens of infected and naïve Balb/c mice at four different time points. This analysis revealed that early response against Leishmania infection is characterized by the upregulation of Th1 markers and M1-macrophage activation molecules such as Ifng, Stat1, Cxcl9, Cxcl10, Ccr5, Cxcr3, Xcl1, and Ccl3. This activation doesn't protect spleen from infection, since parasitic burden rises along time. This marked difference in gene expression between infected and control mice disappears during intermediate stages of infection, probably related to the strong anti-inflammatory and immunosuppresory signals that are activated early upon infection (Ctla4) or remain activated throughout the experiment (Il18bp). The overexpression of these Th1/M1 markers is restored later in the chronic phase (8 wpi), suggesting the generation of a classical "protective response" against leishmaniasis. Nonetheless, the parasitic burden rockets at this timepoint. This apparent contradiction can be explained by the generation of a regulatory immune response characterized by overexpression of Ifng, Tnfa, Il10, and downregulation Il4 that counteracts the Th1/M1 response. This large pool of data was also used to identify potential biomarkers of infection and parasitic burden in spleen, on the bases of two different regression models. Given the results, gene expression signature analysis appears as a useful tool to identify mechanisms involved in disease outcome and to establish a rational approach for the identification of potential biomarkers useful for monitoring disease progression, new therapies or vaccine development., This study was funded by Fundación CajaCanarias (EC) (Ref. 2015 BIO14); Fondo de Investigaciones Sanitarias (FIS)- Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (BV) (N° PI11/02172); Red de Investigación de Centros de Enfermedades Tropicales (RICET)-Ministerio de Economía y Competitividad- Instituto de Salud Carlos III (RD16/0027/0005 (ML) and RD16/0027/0001 (EC, BV); Plan Nacional de I+D+I, Ministerio de Economía y Competitividad (ML) SAF2016-81003-R. YH-S was supported by Beca de Investigación Obra Social La Caixa- Fundación CajaCanarias para postgraduados de la Universidad de La Laguna
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment

  • Pérez-Antón, Elena
  • Egui, Adriana
  • Thomas, María del Carmen
  • Carrilero, Bartolomé
  • Simón, M.
  • López-Ruz, Miguel A.
  • Segovia, Manuel
  • López López, Manuel Carlos
Background: Signs of senescence and the late stages of differentiation associated with the more severe forms of Chagas disease have been described in the Trypanosoma cruzi antigen-specific CD4+ T-cell population. However, the mechanisms involved in these functions are not fully known. To date, little is known about the possible impact of benznidazole treatment on the T. cruzi-specific functional response of CD4+ T cells. Methodology/principal findings: The functional capacity of CD4+ T cells was analyzed by cytometric assays in chronic Chagas disease patients, with indeterminate form (IND) and cardiac alterations (CCC) (25 and 15, respectively) before and after benznidazole treatment. An increase in the multifunctional capacity (expression of IFN-γ, IL-2, TNF-α, perforin and/or granzyme B) of the antigen-specific CD4+ T cells was observed in indeterminate versus cardiac patients, which was associated with the reduced coexpression of inhibitory receptors (2B4, CD160, CTLA-4, PD-1 and/or TIM-3). The functional profile of these cells shows statistically significant differences between IND and CCC (p<0.001), with a higher proportion of CD4+ T cells coexpressing 2 and 3 molecules in IND (54.4% versus 23.1% and 4.1% versus 2.4%, respectively). A significant decrease in the frequencies of CD4+ T cells that coexpress 2, 3 and 4 inhibitory receptors was observed in IND after 24-48 months of treatment (p<0.05, p<0.01 and p<0.05, respectively), which was associated with an increase in antigen-specific multifunctional activity. The IND group showed, at 9-12 months after treatment, an increase in the CD4+ T cell subset coproducing three molecules, which were mainly granzyme B+, perforin+ and IFN-γ+ (1.4% versus 4.5%). Conclusions/significance: A CD4+ T cell dysfunctional process was detected in chronic Chagas disease patients, being more exacerbated in those patients with cardiac symptoms. After short-term benznidazole treatment (9-12 months), indeterminate patients showed a significant increase in the frequency of multifunctional antigen-specific CD4+ T cells., The authors have received funding from the following sources: MCL, grant SAF2016-81003-R from the Programa Estatal I+D+i (Agencia Estatal de Investigación-MINECO) and grant RD16/(0027/0005 from the Network of Tropical Diseases Research RICET (Instituto de Salud Carlos III)) and FEDER; MCT, grant SAF2016-80998-R from the Programa Estatal I+D+i (Agencia Estatal de Investigación - MINECO); MS, grant RD16/0027/0016 from the Network of Tropical Diseases Research RICET (Instituto de Salud Carlos III) and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.